ODN 2006-Type B (human, Negative Control) (VAdv-Ly0070)

CAT Size Price Quantity
VAdv-Ly0070

ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

Specifications
Type
CpG
Molecular Weight
7720
Specificity
TLR9 agonist
Product Form
Powder
Percentage
≥ 95%
Endotoxin
Lower than 0.1 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
ODN 2006 is a type B huamn TLR9 agonist. It induces the MAP kinase pathway and NFκB translocation in purified B cells and could be a potent adjuvant to support humoral immune responses in primates.
Sequence
5'-tgctgcttttgtgcttttgtgctt-3' (24 mer)
Related Product

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.


Online Inquiry

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONTACT US

USA

Tel:
Fax:
Email:
UK

Tel:
Email:
Germany

Tel:
Email:


Follow us on

Shopping Basket